Differential expression of CCR4 in primary cutaneous gamma/delta (γ⁄δ) T cell lymphomas and mycosis fungoides: Significance for diagnosis and therapy

J Dermatol Sci. 2018 Jan;89(1):88-91. doi: 10.1016/j.jdermsci.2017.08.012. Epub 2017 Sep 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor / metabolism*
  • Biopsy
  • CD8-Positive T-Lymphocytes / metabolism
  • Child, Preschool
  • Diagnosis, Differential
  • Humans
  • Lymphoma, T-Cell, Cutaneous / diagnosis*
  • Lymphoma, T-Cell, Cutaneous / drug therapy
  • Lymphoma, T-Cell, Cutaneous / pathology
  • Male
  • Middle Aged
  • Mycosis Fungoides / diagnosis*
  • Mycosis Fungoides / drug therapy
  • Mycosis Fungoides / pathology
  • Patient Selection
  • Receptors, Antigen, T-Cell, gamma-delta / metabolism
  • Receptors, CCR4 / metabolism*
  • Skin / pathology
  • Skin Neoplasms / diagnosis*
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / pathology

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • CCR4 protein, human
  • Receptors, Antigen, T-Cell, gamma-delta
  • Receptors, CCR4
  • mogamulizumab